Company Filing History:
1 out of 75 
1 out of 531 
Years Active: 2003-2008
Title: **The Innovative Work of Claudine Elvire Marie Bruck**
Introduction
Claudine Elvire Marie Bruck is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of innovative polypeptides and polynucleotides that have potential applications in the medical field. With two patents to his name, Bruck is recognized for his work that aims to enhance diagnostic and therapeutic options for serious health conditions.
Latest Patents
Bruck's latest patents include groundbreaking research on CASB618 and CASB414 polypeptides and polynucleotides. The CASB618 patent discloses innovative methods for producing polypeptides through recombinant techniques. These advancements are aimed at utilizing CASB618 polypeptides and polynucleotides in diagnostics and vaccines for the prophylactic and therapeutic treatment of cancers, particularly addressing ovarian and colon cancers, as well as autoimmune diseases. Similarly, the CASB414 patent details methods for producing polypeptides that are overexpressed in various tumors, providing new avenues for diagnostics and therapeutic treatments, especially concerning colon cancers and associated conditions.
Career Highlights
Throughout his career, Claudine Elvire Marie Bruck has been associated with esteemed companies like SmithKline Beecham Biologicals S.A. and GlaxoSmithKline Biologicals S.A. His work in these organizations has been pivotal in furthering research and development in the realm of biotechnology, emphasizing the importance of innovative therapies for critical health issues.
Collaborations
In his professional journey, Bruck has had the privilege of collaborating with distinguished colleagues such as Jean-Pol Cassart and Thierry Coche. These collaborations have played a significant role in enriching his experience and contributing to the advancements in his patents, advancing the potential for practical applications in the medical field.
Conclusion
Claudine Elvire Marie Bruck exemplifies the impactful role of inventors in shaping the future of biotechnology. His patents on CASB618 and CASB414 highlight the relevance of innovation in creating new diagnostic tools and therapies that address serious health concerns. As he continues to work in the field, Bruck remains a vital figure in the pursuit of medical advancements and innovations.